Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years
Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years by 15.96% on an annualized basis producing an average annual return of 23.84%. Currently, Regeneron Pharmaceuticals has a market capitalization of $100.69 billion.
在过去的20年中，Regeneron Pharmicals（纳斯达克股票代码：REGN）的年化表现比市场高出15.96％，平均年回报率为23.84％。目前，Regeneron Pharmicals的市值为1006.9亿美元。
Buying $100 In REGN: If an investor had bought $100 of REGN stock 20 years ago, it would be worth $7,527.35 today based on a price of $913.82 for REGN at the time of writing.
购买100美元的REGN：如果投资者在20年前购买了100美元的REGN股票，那么根据撰写本文时REGN的913.82美元价格，今天的价值将达到7,527.35美元。
Regeneron Pharmaceuticals's Performance Over Last 20 Years
Regeneron Pharmicals在过去20年中的表现
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
最后，这一切的意义何在？从本文中得出的关键见解是，在一段时间内，复合回报可以对您的现金增长产生多大的影响。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。